Alpha Tau Medical Ltd.
DRTS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1,102 | $1,074 | $979 | $776 |
| Gross Profit | -$1,102 | -$1,074 | -$979 | -$776 |
| % Margin | – | – | – | – |
| R&D Expenses | $27,020 | $26,424 | $20,890 | $11,447 |
| G&A Expenses | $6,673 | $7,332 | $10,272 | $1,861 |
| SG&A Expenses | $7,920 | $9,256 | $11,246 | $2,343 |
| Sales & Mktg Exp. | $1,247 | $1,924 | $974 | $482 |
| Other Operating Expenses | $0 | -$1,074 | $0 | $0 |
| Operating Expenses | $34,940 | $34,606 | $32,136 | $13,790 |
| Operating Income | -$36,042 | $35,680 | -$32,136 | -$13,790 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $4,298 | $6,539 | -$1,606 | -$13,474 |
| Pre-Tax Income | -$31,744 | -$29,141 | -$33,742 | -$27,264 |
| Tax Expense | $6 | $16 | $20 | $7 |
| Net Income | -$31,750 | -$29,157 | -$33,762 | -$27,271 |
| % Margin | – | – | – | – |
| EPS | -0.45 | -0.42 | -0.53 | -0.67 |
| % Growth | -7.1% | 20.8% | 20.9% | – |
| EPS Diluted | -0.45 | -0.42 | -0.53 | -0.67 |
| Weighted Avg Shares Out | 69,928 | 69,378 | 63,535 | 40,529 |
| Weighted Avg Shares Out Dil | 69,928 | 69,378 | 63,535 | 40,529 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,277 | $4,755 | $1,790 | $211 |
| Interest Expense | $344 | $39 | $1,769 | $13,273 |
| Depreciation & Amortization | $1,102 | $1,074 | $979 | $776 |
| EBITDA | -$30,298 | -$28,028 | -$32,742 | -$13,215 |
| % Margin | – | – | – | – |